F-STAR THERAPEUTICS INC - COM (FSTX)

CUSIP: 30315R107

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
6,897,095
Share change
-218,042
Total reported value
$35,309,000
Price per share
$5.12
Number of holders
51
Value change
-$1,417,934
Number of buys
29
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q3 2022

As of 30 Sep 2022, F-STAR THERAPEUTICS INC - COM (FSTX) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,897,095 shares. The largest 10 holders included Rock Springs Capital Management LP, Atlas Venture Life Science Advisors, LLC, DAFNA Capital Management LLC, Atlas Venture Advisors, Inc., Russell Investments Group, Ltd., VANGUARD GROUP INC, BlackRock Inc., Knott David M Jr, BARCLAYS PLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.